AOD 9604 5mg

AOD 9604 5mg

Product Overview

AOD 9604 5mg is a peptide-related research product listed by Peptide Depot for customers seeking information about AOD-9604 and its scientific background. AOD-9604 is a synthetic 16-amino-acid peptide based on a modified fragment of human growth hormone (hGH). It has been investigated in scientific research involving lipid metabolism and related biological processes.

The product name specifies a quantity of 5mg. However, the brand, manufacturer, physical format, packaging, purity, storage requirements and batch documentation have not been provided. These details should be checked against the actual product label and supplier documentation before publication.

AOD-9604 is also described as a modified fragment of the C-terminal region of human growth hormone. It is scientifically distinct from full-length growth hormone. Its research history includes animal studies and human clinical investigations, but those studies do not establish that a commercial 5mg product is safe or effective for human use.

WHY CHOOSE AOD 9604 5mg?

AOD-9604 has a recognisable identity in the scientific literature, making accurate compound identification important for researchers reviewing published work or comparing research materials.

The stated 5mg quantity provides a clear catalogue identifier. However, the quantity alone does not confirm the product’s purity, concentration, physical presentation or suitability for any particular laboratory project. Customers should review the product label and any available batch-specific documentation before purchasing.

A transparent product listing should identify the compound and stated quantity clearly. Where available, it should also provide the manufacturer, packaging details, batch identification and a Certificate of Analysis (CoA). These details help customers assess what is being offered rather than relying on assumptions based on a product name.

No brand or manufacturer has been supplied for this listing. Consequently, no specific manufacturing standards, independent testing, purity level or product-consistency claims can be made. Packaging should also be described only after the actual product photographs or supplier documentation confirm its presentation.

RESEARCH INFORMATION

AOD-9604 is a synthetic analogue of a lipolytic region of human growth hormone. Scientific descriptions identify it as a modified hexadecapeptide associated with the C-terminal region of hGH. Research has examined its potential relationship with lipid metabolism, including processes studied in laboratory and animal models.

A paper published in 2000 and indexed on PubMed investigated AOD-9604 in obese Zucker rats. The researchers examined metabolic activity and changes in adipose-tissue lipolysis. These findings relate to that particular animal model and cannot be used as proof of a comparable effect in humans. Read the PubMed research record.

AOD-9604 was also investigated in human clinical studies. A registered Phase IIb study examined oral AOD-9604 tablets in adults with obesity. Importantly, the FDA’s 2024 Pharmacy Compounding Advisory Committee materials report that the larger 24-week OPTIONS study did not demonstrate a statistically significant difference in weight loss between AOD-9604 and placebo. This is an important limitation when reviewing claims about the compound. Review the trial registration and FDA committee materials.

The existence of animal studies and human investigations does not establish a proven therapeutic benefit. It is particularly important not to transfer findings from one experimental formulation or route of administration to a different commercial product. The available information for this listing does not establish its formulation or intended route of use.

For customers researching AOD-9604, the original scientific publications and regulatory documents provide more reliable context than promotional claims. Research findings should be assessed according to their study design, limitations and relevance to the material being investigated.

QUALITY & TRUST

A trustworthy research-product listing should provide accurate specifications and supporting information where available. Useful documentation may include:

• A clear product label showing the compound name and stated quantity.

• Manufacturer or supplier identification.

• Batch or lot number.

• A batch-specific Certificate of Analysis, if available.

• Analytical results that genuinely relate to the product being sold.

• Clear information about the product’s intended purpose and packaging.

No purity percentage, independent laboratory report, manufacturing certification or batch record has been supplied for AOD 9604 5mg. These details should not be assumed from the product name or quantity.

If a CoA or analytical report becomes available, it should be checked to confirm that it identifies the correct compound and corresponds to the batch being offered. Product photographs should also show the actual item rather than a generic or unrelated peptide container.

BUYING WITH CONFIDENCE

When comparing research-product suppliers, customers should look for transparent specifications, accurate labelling, accessible documentation and clear contact information. It is also sensible to review checkout security, shipping terms and the seller’s published policies before placing an order.

In the United Kingdom, the MHRA considers a product’s claims, properties and presentation when determining whether it falls within the definition of a medicine. A research-use statement alone does not determine a product’s regulatory status. The official MHRA guidance on borderline products explains the factors involved.

IMPORTANT RESEARCH-USE NOTICE

AOD-9604 is an investigational peptide discussed in scientific literature. The intended-use designation and regulatory status of this specific 5mg product have not been confirmed from the information supplied. If it is supplied exclusively as research material, its labelling and marketing should accurately state that purpose. It must not be presented as an approved medicine or as a treatment for any condition. This product description does not provide dosing or human administration instructions.